Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Biocon Biologics Symposium on '100 Years of Insulin - Delivering on Universal Access & Equitable Care' Resonates Well With Leading KOLs at IDF Congress 2019 2019-12-12 09:00
Human Microbiome Market to Reach $6.08 Billion by 2023, Powered by the High Growth in Over-the-Counter Probiotics 2019-12-11 23:55
iX Biopharma Reports on Outcome of Wafermine End-of-phase 2 Meeting with US FDA 2019-12-11 22:00
SoClean Continues Global Expansion with Appointment of Francis Choi as Vice President of Asia-Pacific Market 2019-12-11 21:01
Tenth Record-Breaking Year in a Row for ZEISS 2019-12-11 20:59
GemVax announced phase II results of GV1001 for Alzheimer's disease treatment at CTAD 2019 2019-12-11 18:40
Xinhua Silk Road: E. China Nanjing Jiangbei New Area aims to develop life and health industry 2019-12-11 16:52
CStone announces enrollment target reached in the global Phase III VOYAGER trial of avapritinib in Chinese patients with third-line GIST 2019-12-11 11:00
AGC Biologics Expands Plasmid DNA Offering 2019-12-11 09:06
Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma 2019-12-11 08:41
Ascentage Pharma Releases Updated Data of its Novel BCR-ABL Inhibitor, HQP1351, in an Oral Presentation Nominated for "Best of ASH" 2019-12-11 08:00
Vision Impact Institute: New Reports on State of Vision Will Renew Global Focus on the Societal Impact of Poor Vision 2019-12-11 03:42
Breakthrough in Medical Electronics - A Novel Mixed & Augmented Reality Smart Glasses Surgical Navigation Solution 2019-12-10 16:34
Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at the 2019 ASH Annual Meeting 2019-12-10 16:00
CStone's anti-PD-L1 antibody demonstrates promising antitumor activity with a complete response rate of 33.3% and a good safety profile in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma 2019-12-10 11:38
Farrer Park Hospital Implements Non-Invasive Treatment for Prostate Cancer Patients in Singapore 2019-12-10 08:15
Townsville Hospital Treats First Australian Patient With Elekta Unity MR-Linac, a Transformative Approach to Precision Radiation Therapy 2019-12-10 08:13
TechMah Medical & LimaCorporate Receive First 510k Approval for Smart SPACE Digital Technology 2019-12-10 02:08
Gracell Announces Progressive Outcomes from Multiple Human Clinical Trials to Investigate FasTCAR and Dual CAR Cell Platform Technologies 2019-12-09 22:00
Publication of First In-Human Data Reveals Safety & Efficacy of Tigilanol Tiglate in Solid Tumours 2019-12-09 21:01
1 605 606 607 608 609 962